KRYS · Krystal Biotech Inc.
AI read · Neutral
The AI's read
Its current product sales are growing, and reported profit and sales both topped estimates. These results support the business today. But expected results from 2 studies have moved later, and enrollment in 1 has been slower than expected. An analyst says careful study rules may help produce useful results, but the studies have not reported outcomes yet. The story gives no clear reason for one side to outweigh the other.